Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
      Reference: '178500'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '616371'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '616373'
      Source: OMIM
  Genes:
  - Gene:
      ExternalReferences: []
      Name: surfactant protein A1
      Symbol: SFTPA1
  - Gene:
      ExternalReferences: []
      Name: desmoplakin
      Symbol: DSP
  - Gene:
      ExternalReferences: []
      Name: telomerase reverse transcriptase
      Symbol: TERT
  - Gene:
      ExternalReferences: []
      Name: telomerase RNA component
      Symbol: TERC
  - Gene:
      ExternalReferences: []
      Name: mucin 5B, oligomeric mucus/gel-forming
      Symbol: MUC5B
  - Gene:
      ExternalReferences: []
      Name: surfactant protein A2
      Symbol: SFTPA2
  - Gene:
      ExternalReferences: []
      Name: regulator of telomere elongation helicase 1
      Symbol: RTEL1
  - Gene:
      ExternalReferences: []
      Name: family with sequence similarity 13 member A
      Symbol: FAM13A
  - Gene:
      ExternalReferences: []
      Name: STN1 subunit of CST complex
      Symbol: STN1
  - Gene:
      ExternalReferences: []
      Name: ATPase phospholipid transporting 11A
      Symbol: ATP11A
  - Gene:
      ExternalReferences: []
      Name: dipeptidyl peptidase 9
      Symbol: DPP9
  - Gene:
      ExternalReferences: []
      Name: poly(A)-specific ribonuclease
      Symbol: PARN
  - Gene:
      ExternalReferences: []
      Name: surfactant protein C
      Symbol: SFTPC
  - Gene:
      ExternalReferences: []
      Name: ATP binding cassette subfamily A member 3
      Symbol: ABCA3
  Label: Idiopathic pulmonary fibrosis
  ORPHAcode: '2032'
  ORPHApacketId: '2032'
  PURL: http://www.orpha.net/ORDO/Orphanet_2032
  Parents:
  - Parent:
    - Label: Idiopathic interstitial pneumonia
      ORPHAcode: '98300'
  - Parent:
    - Label: Disease associated with a genetic susceptibility or tested for a biomarker
      ORPHAcode: '231957'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0006530
      HPOTerm: Interstitial pulmonary abnormality
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002020
      HPOTerm: Gastroesophageal reflux
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002110
      HPOTerm: Bronchiectasis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002206
      HPOTerm: Pulmonary fibrosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002875
      HPOTerm: Exertional dyspnea
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012735
      HPOTerm: Cough
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025175
      HPOTerm: Honeycomb lung
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025179
      HPOTerm: Ground-glass opacification on pulmonary HRCT
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025390
      HPOTerm: Reticular pattern on pulmonary HRCT
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030830
      HPOTerm: Crackles
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100759
      HPOTerm: Clubbing of fingers
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0010444
      HPOTerm: Pulmonary insufficiency
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 7921471[PMID]_23204124[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 23204124[PMID]_European Medicines Agency 2018[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11484513[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 23204124[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 12693805[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: ORPHANET_16844727[PMID]_21525528[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11923553[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 12693805[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 23204124[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 23204124[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19345567[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 19345567[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 18657060[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22954482[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22954482[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: ORPHANET_23204124[PMID]_7921471[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: IPF
  TextSection:
    Contents: An interstitial lung disease with a poor prognosis that is characterized
      by the progressive formation of scar tissue within the lungs in the absence
      of any known cause.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Multigenic/multifactorial
  copyright: Orphanet (c) 2022
  creationDate: '2022-06-14 15:58:09'
  version: 1.3.16 / 4.1.7 [2022-01-26] (orientdb version)
